Supplementary Tables S1-8 from Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor–positive Breast Cancer

Table S1: IC50 data; Table S2: RPPA normalized raw data; Table S3: Differentially expressed analysis in all RNA-seq data; Table S4: Summary of statistical analysis results cell cycle; Table S5: Mutational landscape of the PDX1415 and PDX1526; Table S6: Focal copy number variations of the PDX1415 and PDX1526 models; Table S7: Beta score of the CRISPR/CAS9 KO screening; Table S8: Antibodies